Search Results - "SOYSAL, T"

Refine Results
  1. 1

    Macrosegregation in dissimilar-metal fusion welding by Soysal, T., Kou, S., Tat, D., Pasang, T.

    Published in Acta materialia (15-05-2016)
    “…Solute segregation on a macroscopic scale in a weld between two dissimilar metals or alloys has long been recognized, but fundamental understanding of…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    An Unusual Presentation of a Chronic Lymphocytic Leukemia Patient with 17p Deletion After Reduced-Intensity Transplantation: Richter Syndrome and Concomitant Graft-Versus-Host Disease—Case Report by Salihoglu, A, Ozbalak, M, Keskin, D, Tecimer, T, Soysal, T, Ferhanoglu, B

    Published in Transplantation proceedings (01-09-2013)
    “…Abstract Chronic lymphocytic leukemia (CLL) patients with 17p deletion comprise a challenging subgroup associated with poor overall survival. These patients…”
    Get full text
    Journal Article
  5. 5

    Association of “Controlling Nutritional Status Index” and “Prognostic Nutritional Index” with intensive care unit survival in elderly patients by Kos, M, Titiz, H, Onec, B, Soysal, T, Kutlucan, A, Sahiner Emen, S, Kutlucan, L

    Published in European geriatric medicine (01-02-2016)
    “…Abstract Objectives Providing proper nutritional support for the intensive care unit (ICU) patients is only possible with assessment of malnutrition. In this…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Overview of 321 patients with idiopathic thrombocytopenic purpura: Retrospective analysis of the clinical features and response to therapy by PAMUK, G. E, PAMUK, Ö. N, BASLAR, Z, ÖNGÖREN, S, SOYSAL, T, FERHANOGLU, B, AYDIN, Y, ÜLKÜ, B, AKTUGLU, G, AKMAN, N

    Published in Annals of hematology (01-08-2002)
    “…In this retrospective study, we evaluated the clinical features and the effects of various treatment modalities on the clinical course in patients diagnosed…”
    Get full text
    Journal Article
  10. 10

    Successful management of cryoglobulinemia-induced leukocytoclastic vasculitis with thalidomide in a patient with multiple myeloma by Cem Ar, M, Soysal, Teoman, Hatemi, Gulen, Salihoglu, Ayse, Yazici, Hasan, Ulku, Birsen

    Published in Annals of hematology (01-09-2005)
    “…Leukocytoclastic vasculitis (LV) is a systemic inflammatory disorder involving mostly the small vessels. It is characterised by segmental angiocentric…”
    Get full text
    Journal Article
  11. 11
  12. 12

    A reappraisal of the association between Behçet's disease, myelodysplastic syndrome and the presence of trisomy 8: a systematic literature review by Esatoglu, Sinem Nihal, Hatemi, Gulen, Salihoglu, Ayse, Hatemi, Ibrahim, Soysal, Teoman, Celik, Aykut Ferhat

    Published in Clinical and experimental rheumatology (01-11-2015)
    “…A number of patients with Behçet's disease (BD) associated with myelodysplastic syndrome (MDS) with or without trisomy 8 have been reported. A high frequency…”
    Get full text
    Journal Article
  13. 13

    An Overview of Lenalidomide in Combination with Rituximab for the Treatment of Adult Patients with Follicular Lymphoma: The Evidence to Date by Yilmaz, Umut, Salihoglu, Ayse, Soysal, Teoman

    Published in Drug design, development and therapy (01-01-2021)
    “…Follicular lymphoma (FL) is an indolent (low-grade) malignancy of B cells and is among the most common hematological cancers affecting adults. Its clinical…”
    Get full text
    Journal Article
  14. 14
  15. 15

    PB1904 PROPHYLAXIS FOR OCCULT HBV INFECTION UNDER IBRUTINIB THERAPY: MANDATORY OR OPTIONAL? by Ercaliskan, A., Eskazan, A.E., Salihoglu, A., Keskin, D., Ozmen, D., Elverdi, T., Ar, M.C., Soysal, T.

    Published in HemaSphere (01-06-2019)
    “…Background: Ibrutinib is a Bruton's tyrosine kinase inhibitor which plays a critical role in the management of some B cell malignancies. Although there are…”
    Get full text
    Journal Article
  16. 16
  17. 17

    PB1929 POTENTIAL DRUG‐DRUG INTERACTIONS AMONG PATIENTS WITH CHRONIC MYELOID LEUKEMIA UNDER TYROSINE KINASE INHIBITOR THERAPY WITH IMATINIB by Kunbaz, A., Eskazan, A.E., Ozmen, D., Sasmaz, A., Hakmi, A., Shahab, S., Elverdi, T., Salihoglu, A., Ar, M.C., Soysal, T.

    Published in HemaSphere (01-06-2019)
    “…Background: The introduction of imatinib (IM) has revolutionized the treatment of chronic myeloid leukemia (CML). CML patients (pts) achieving optimal…”
    Get full text
    Journal Article
  18. 18

    Congenital dyserythropoietic anemia type I with ringed sideroblasts by Soysal, T, Akun, E, Ozaras, R, Aki, H, Ozturk, M, Tuzuner, N

    Published in Haematologia (01-01-2000)
    “…A 25-year-old male with anemia, jaundice and liver dysfunction was admitted to our institution. Anisopoikilocytosis with tear-drop forms, polychromasia,…”
    Get more information
    Journal Article
  19. 19
  20. 20